Microbot Medical’s vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures within the human body, and offer physicians and their patients less invasive and more precise solutions. The company’s innovations tap into one of the fastest-growing spaces in the medical field, the minimal invasive space. Microbot Medical develops micro-robotic medical devices that provide doctors and surgeons with new technological capabilities to improve a patient’s health, comfort and quality of life. Microbot’s current technological platforms, ViRob™, TipCAT™and CardioSert™, are comprised of highly advanced technologies from which the Company is currently developing its first product candidate: the Self-Cleaning Shunt, or SCS™, for the treatment of hydrocephalus and normal pressure hydrocephalus. To learn more about Microbot Medical, visit www.microbotmedical.com.
Company’s Keywords:
microrobotics
<30
<2000000
<2010